本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Quoin Pharmaceuticals

8.48
-0.2600-2.97%
盤後8.480.00000.00%18:12 EDT
成交量:3,076.00
成交額:2.62萬
市值:498.76萬
市盈率:-0.22
高:8.99
開:8.42
低:8.42
收:8.74
資料載入中...
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/11/12

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/08/10

SEC問詢函

CORRESP [Cover] - Correspondence
2021/08/05

SEC問詢函

CORRESP [Cover] - Correspondence
2021/08/03

交易所摘牌聲明

25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2021/07/16

SEC問詢函

CORRESP [Cover] - Correspondence
2021/03/29

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/13

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/08/04

[修訂]年度報告

20-F/A [Amend] - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/04/22

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/04/03

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/01/17

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/01/10

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2019/06/20

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2019/03/18

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]